BEIGENE, LTD.

(BGNE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Analyst Recommendations on BEIGENE, LTD.
05/09Morgan Stanley Lowers BeiGene's Price Target to $300 From $338, Maintains Overweight Ra..
MT
04/12Morgan Stanley Adjusts BeiGene's Price Target to $338 from $330, Keeps Overweight Ratin..
MT
03/17SVB Leerink Cuts BeiGene to Market Perform From Outperform, Price Target to $177 From $..
MT
03/01Nomura Upgrades BeiGene to Buy From Neutral, Adjusts Price Target to $310.62 From $293...
MT
03/01Nomura Upgrades BeiGene to Buy From Neutral, Adjusts Price Target to HK$186.85 From HK$..
MT
02/28Macquarie Lowers BeiGene's Price Target to $301.60 From $312.80, Maintains Outperform R..
MT
02/28Morgan Stanley Lowers BeiGene's Price Target to $330 From $360, Maintains Overweight Ra..
MT
02/28Goldman Sachs Lowers BeiGene's Price Target to $364.32 From $410.60, Maintains Buy Rati..
MT
02/28SVB Leerink Adjusts BeiGene's Price Target to $300 from $334, Maintains Outperform Rati..
MT
01/18Morgan Stanley Adjusts BeiGene's Price Target to $360 from $407, Keeps Overweight Ratin..
MT
2021Nomura Adjusts BeiGene's Price Target to $293.28 From $355.83, Maintains Neutral Rating
MT
2021Nomura Adjusts Beigene's Price Target to HK$176.97 From HK$214.05, Keeps at Neutral
MT
2021Nomura Adjusts BeiGene to Neutral From Not Rated, Sets $355.83 Price Target
MT
2021BEIGENE : SVB Leerink Adjusts Price Target on BeiGene to $414 From $417, Maintains Outperf..
MT
2021BEIGENE : Bernstein Starts BeiGene at Outperform With $431 Price Target
MT
2021BEIGENE : Morgan Stanley Adjusts Price Target on BeiGene to $407 From $409, Maintains Over..
MT
2021BEIGENE : SVB Leerink Adjusts BeiGene's Price Target to $417 from $388, Keeps Outperform R..
MT
2021BEIGENE : Morgan Stanley Adjusts Price Target on BeiGene to $409 From $357, Maintains Over..
MT
2021BEIGENE : Morgan Stanley Adjusts BeiGene's Price Target to $357 from $375, Keeps Overweigh..
MT
2021BEIGENE : HSBC Adjusts BeiGene's Price Target to $385 from $296, Keeps Buy Rating
MT
2021BEIGENE : China Renaissance Initiates Coverage on BeiGene With Buy Rating
MT
2021BEIGENE : CLSA Downgrades BeiGene to Underperform From Outperform, Adjusts Price Target to..
MT
2021BEIGENE : Cowen & Co. Adjusts Price Target on BeiGene to $429 From $348, Maintains Outperf..
MT
2021BEIGENE : Morgan Stanley Adjusts BeiGene PT to $375 From $310, Maintains Overweight Rating
MT
2020BEIGENE : Ladenburg Thalmann Upgrades BeiGene to Buy From Neutral; Price Target is $278
MT
2020BEIGENE : SVB Leerink Adjusts BeiGene's Price Target to $327 From $240, Keeps at Outperfor..
MT
2020BEIGENE : Morgan Stanley Adjusts BeiGene PT to $310 From $270, Maintains Overweight Rating
MT
2020BEIGENE : Ladenburg Thalmann Downgrades BeiGene to Neutral from Buy
MT
2020BEIGENE : Piper Sandler Downgrades BeiGene to Underweight From Neutral; Price Target is $1..
MT